Goldman Sachs’s Harpoon Therapeutics, Inc. Common Stock HARP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-48,948
| Closed | -$557K | – | 5032 |
|
|
2023
Q4 | $557K | Buy |
+48,948
| New | +$557K | ﹤0.01% | 3894 |
|
|
2023
Q1 | – | Sell |
-11,160
| Closed | -$81K | – | 5354 |
|
|
2022
Q4 | $81K | Sell |
11,160
-1,497
| -12% | -$10.9K | ﹤0.01% | 4716 |
|
|
2022
Q3 | $123K | Sell |
12,657
-8,235
| -39% | -$80K | ﹤0.01% | 4866 |
|
|
2022
Q2 | $399K | Buy |
20,892
+4,735
| +29% | +$90.4K | ﹤0.01% | 4526 |
|
|
2022
Q1 | $803K | Buy |
16,157
+4,947
| +44% | +$246K | ﹤0.01% | 4267 |
|
|
2021
Q4 | $847K | Buy |
11,210
+2,470
| +28% | +$187K | ﹤0.01% | 4169 |
|
|
2021
Q3 | $690K | Sell |
8,740
-13,564
| -61% | -$1.07M | ﹤0.01% | 4205 |
|
|
2021
Q2 | $3.09M | Buy |
22,304
+17,884
| +405% | +$2.48M | ﹤0.01% | 3153 |
|
|
2021
Q1 | $925K | Buy |
4,420
+1,178
| +36% | +$247K | ﹤0.01% | 3970 |
|
|
2020
Q4 | $538K | Sell |
3,242
-56
| -2% | -$9.29K | ﹤0.01% | 3784 |
|
|
2020
Q3 | $560K | Sell |
3,298
-2,265
| -41% | -$385K | ﹤0.01% | 3617 |
|
|
2020
Q2 | $924K | Buy |
+5,563
| New | +$924K | ﹤0.01% | 3274 |
|
|
2020
Q1 | – | Sell |
-1,106
| Closed | -$164K | – | 4597 |
|
|
2019
Q4 | $164K | Sell |
1,106
-1,039
| -48% | -$154K | ﹤0.01% | 4033 |
|
|
2019
Q3 | $293K | Buy |
+2,145
| New | +$293K | ﹤0.01% | 3803 |
|
|
2019
Q2 | – | Sell |
-2,936
| Closed | -$278K | – | 4319 |
|
|
2019
Q1 | $278K | Buy |
+2,936
| New | +$278K | ﹤0.01% | 3769 |
|